My Quote Request
No products added yet
6505-01-108-9617
20 Products
NDC00094-0040-06
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011089617
NSN
6505-01-108-9617
NDC00094-0040-06
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011089617
NSN
6505-01-108-9617
MFG
DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS DOPAMINE HYDROCHLORIDE PER CUBIC CENTIMETER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00074-5820-01
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011089617
NSN
6505-01-108-9617
NDC00074-5820-01
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011089617
NSN
6505-01-108-9617
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS DOPAMINE HYDROCHLORIDE PER CUBIC CENTIMETER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00024-1353-01
PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP
NSN, MFG P/N
6505011094221
NSN
6505-01-109-4221
NDC00024-1353-01
PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP
NSN, MFG P/N
6505011094221
NSN
6505-01-109-4221
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
NEO-SYNEPHRINE
PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP
NSN, MFG P/N
6505011094221
NSN
6505-01-109-4221
NEO-SYNEPHRINE
PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP
NSN, MFG P/N
6505011094221
NSN
6505-01-109-4221
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
NEO-SYNEPHRINE SPRAY
PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP
NSN, MFG P/N
6505011094221
NSN
6505-01-109-4221
NEO-SYNEPHRINE SPRAY
PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION,USP
NSN, MFG P/N
6505011094221
NSN
6505-01-109-4221
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYLEPHRINE HYDROCHLORIDE NASAL SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
C71
MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011098165
NSN
6505-01-109-8165
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 3.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 25.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 1.200 MILLIGRAMS PYRIDOXINE ACTIVE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS;COATING FEATURE:SUGAR;ADMINISTRATION:ORAL NONCHEWABLE;
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: INGREDIENT AND 3.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT AND 10000.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 400.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 6.600 INTERNATIONAL
~2: UNITS VITAMIN E ACTIVE INGREDIENT
Related Searches:
MULTICEBRIN
MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011098165
NSN
6505-01-109-8165
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 3.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 25.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 1.200 MILLIGRAMS PYRIDOXINE ACTIVE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS;COATING FEATURE:SUGAR;ADMINISTRATION:ORAL NONCHEWABLE;
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: INGREDIENT AND 3.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT AND 10000.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 400.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 6.600 INTERNATIONAL
~2: UNITS VITAMIN E ACTIVE INGREDIENT
Related Searches:
NDC00002-0371-33
MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011098165
NSN
6505-01-109-8165
NDC00002-0371-33
MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011098165
NSN
6505-01-109-8165
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 3.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 25.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 1.200 MILLIGRAMS PYRIDOXINE ACTIVE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS;COATING FEATURE:SUGAR;ADMINISTRATION:ORAL NONCHEWABLE;
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: INGREDIENT AND 3.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT AND 10000.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 400.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 6.600 INTERNATIONAL
~2: UNITS VITAMIN E ACTIVE INGREDIENT
Related Searches:
NDC00597-0017-90
DIPYRIDAMOLE TABLETS,USP
NSN, MFG P/N
6505011099469
NSN
6505-01-109-9469
NDC00597-0017-90
DIPYRIDAMOLE TABLETS,USP
NSN, MFG P/N
6505011099469
NSN
6505-01-109-9469
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DIPYRIDAMOLE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER-INGLEHEIM
Related Searches:
PERSANTINE
DIPYRIDAMOLE TABLETS,USP
NSN, MFG P/N
6505011099469
NSN
6505-01-109-9469
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DIPYRIDAMOLE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER-INGLEHEIM
Related Searches:
NDC00703-3524-01
DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505011099472
NSN
6505-01-109-9472
NDC00703-3524-01
DEXAMETHASONE SODIUM PHOSPHATE INJECTION,USP
NSN, MFG P/N
6505011099472
NSN
6505-01-109-9472
MFG
SICOR PHARMACEUTICALS SALES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DEXAMETHASONE SODIUM PHOSPHATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP 10MG/ML 10ML VIAL
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ORGANON
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CORGARD TABLETS
NADOLOL TABLETS,USP
NSN, MFG P/N
6505011101994
NSN
6505-01-110-1994
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 80MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00003-0241-76
NADOLOL TABLETS,USP
NSN, MFG P/N
6505011101994
NSN
6505-01-110-1994
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 80MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-1132-01
NADOLOL TABLETS,USP
NSN, MFG P/N
6505011101994
NSN
6505-01-110-1994
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 80MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DILANTIN
PHENYTOIN TABLETS,USP
NSN, MFG P/N
6505011102026
NSN
6505-01-110-2026
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENYTOIN ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTOIN TABLETS USP 50MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,PARKE-DAVIS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
DILANTIN INFATABS
PHENYTOIN TABLETS,USP
NSN, MFG P/N
6505011102026
NSN
6505-01-110-2026
DILANTIN INFATABS
PHENYTOIN TABLETS,USP
NSN, MFG P/N
6505011102026
NSN
6505-01-110-2026
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENYTOIN ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTOIN TABLETS USP 50MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,PARKE-DAVIS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00071-0007-40
PHENYTOIN TABLETS,USP
NSN, MFG P/N
6505011102026
NSN
6505-01-110-2026
NDC00071-0007-40
PHENYTOIN TABLETS,USP
NSN, MFG P/N
6505011102026
NSN
6505-01-110-2026
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENYTOIN ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTOIN TABLETS USP 50MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,PARKE-DAVIS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
0201
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
0201
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
MFG
CETYLITE INDUSTRIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BENZALKONIUM CHLORIDE ACTIVE INGREDIENT AND 14.000 PERCENTAGE, W/V BENZOCAINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V BUTAMBEN ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V TETRACAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.005
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BENZOCAINE BUTAMBEN AND TETRACAINE HCL TOPICAL AEROSOL 56GM
PRIMARY CONTAINER CONTENT QUANTITY: 56.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE, AEROSOL
SPECIAL FEATURES: IN ABLAND WATER SOLUABLE BASE; CONTAINS 0.50 PCT BENZALKONIUM CHLORIDE AND 0.05 PCT CETYL DIMETHYL ETHYL AMMONIUM BROMIDE AS PRESERVATIVES; WITH ONE DETACHABLE,STAINLESS STEEL CANNULA,WHICH,WHEN ATTACHED TO THE PROTRUDING PLASTIC TUBING ON THE
~1: BOTTLE,PERMITS ADMINISTRATION OF ANESTHETIC TO THE DESIRED SITE OF APPLICATION WHEN ACTIVATED
~1: PERCENTAGE W/V CETYL DIMETHYL ETHYL AMMONIUM BROMIDE ACTIVE INGREDIENT
Related Searches:
189-7594
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
189-7594
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
MFG
PATTERSON DENTAL SUPPLY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BENZALKONIUM CHLORIDE ACTIVE INGREDIENT AND 14.000 PERCENTAGE, W/V BENZOCAINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V BUTAMBEN ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V TETRACAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.005
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BENZOCAINE BUTAMBEN AND TETRACAINE HCL TOPICAL AEROSOL 56GM
PRIMARY CONTAINER CONTENT QUANTITY: 56.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE, AEROSOL
SPECIAL FEATURES: IN ABLAND WATER SOLUABLE BASE; CONTAINS 0.50 PCT BENZALKONIUM CHLORIDE AND 0.05 PCT CETYL DIMETHYL ETHYL AMMONIUM BROMIDE AS PRESERVATIVES; WITH ONE DETACHABLE,STAINLESS STEEL CANNULA,WHICH,WHEN ATTACHED TO THE PROTRUDING PLASTIC TUBING ON THE
~1: BOTTLE,PERMITS ADMINISTRATION OF ANESTHETIC TO THE DESIRED SITE OF APPLICATION WHEN ACTIVATED
~1: PERCENTAGE W/V CETYL DIMETHYL ETHYL AMMONIUM BROMIDE ACTIVE INGREDIENT
Related Searches:
CETACAINE SPRAY
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
CETACAINE SPRAY
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
MFG
CETYLITE INDUSTRIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BENZALKONIUM CHLORIDE ACTIVE INGREDIENT AND 14.000 PERCENTAGE, W/V BENZOCAINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V BUTAMBEN ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V TETRACAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.005
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BENZOCAINE BUTAMBEN AND TETRACAINE HCL TOPICAL AEROSOL 56GM
PRIMARY CONTAINER CONTENT QUANTITY: 56.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE, AEROSOL
SPECIAL FEATURES: IN ABLAND WATER SOLUABLE BASE; CONTAINS 0.50 PCT BENZALKONIUM CHLORIDE AND 0.05 PCT CETYL DIMETHYL ETHYL AMMONIUM BROMIDE AS PRESERVATIVES; WITH ONE DETACHABLE,STAINLESS STEEL CANNULA,WHICH,WHEN ATTACHED TO THE PROTRUDING PLASTIC TUBING ON THE
~1: BOTTLE,PERMITS ADMINISTRATION OF ANESTHETIC TO THE DESIRED SITE OF APPLICATION WHEN ACTIVATED
~1: PERCENTAGE W/V CETYL DIMETHYL ETHYL AMMONIUM BROMIDE ACTIVE INGREDIENT
